Bumper Offer - Urjas oil Just @ Rs. 1
Zyrova is a prescription drug, available for use as Capsule, Tablet. Primarily, it is used for the treatment of High Cholesterol. Secondary and off-label uses of Zyrova have also been mentioned below.
The optimal dosage of Zyrova is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Zyrova can also lead to other problems, which have been listed below. Such side effects of Zyrova normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Zyrova has a Severe effect for pregnant women and Mild effect on lactating mothers. It is important to know if Zyrova has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zyrova related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy must refrain from the use of Zyrova since this can cause severe adverse effects. Some other conditions that can be affected by Zyrova are listed in the contraindications section below.
Additionally, Zyrova may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Zyrova is safe while driving, and is is addictive in nature.
Zyrova is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Zyrova safe for pregnant women?
Pregnant women may get severe side effects after taking Zyrova. If you are pregnant, do not take Zyrova without a doctor's advice.
Is the use of Zyrova safe during breastfeeding?
Zyrova has been seen to have minimal side effects on breastfeeding women.
What is the effect of Zyrova on the Kidneys?
Zyrova can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Zyrova on the Liver?
You may experience side effects on your liver after taking Zyrova. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zyrova on the Heart?
Zyrova is rarely harmful for the heart.
Zyrova should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Zyrova unless your doctor advises you to do so -
Is this Zyrova habit forming or addictive?
No, there is no any evidence that Zyrova is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Zyrova does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Zyrova only on doctor's advice.
Is it able to treat mental disorders?
Zyrova is unable to treat or cure mental disorders.
Interaction between Food and Zyrova
Some foods when eaten with Zyrova can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Zyrova
Consuming Zyrova with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650